The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Wyzga Michael S since year 2005.
The trader's CIK number is 1201256.
At the time of this reporting, Wyzga Michael S is the Executive VP and CFO of Akebia Therapeutics, Inc. .
(stock ticker symbol AKBA).
See this page for all insider trading activities at Akebia Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-03-25||AKBA||Akebia Therapeutics, Inc.||Buy||1,500||17.00||25,500|
|2011-04-04||GENZ||Genzyme Corp||Option Ex||29,250||.00||0|
|2010-05-24||GENZ||Genzyme Corp||Option Ex||15,000||.00||0|
|2008-08-12||GENZ||Genzyme Corp||Option Ex||29,390||35.51||1,043,727|
|2007-12-17||GENZ||Genzyme Corp||Option Ex||5,140||43.36||222,870|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wyzga Michael S (Executive VP and CFO of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.